The goal of the Stem Cell Engineering Research Group (SCERG) is to develop cell production systems for the ex vivo expansion of stem cells and/or their controlled differentiation into specific cell types or microtissues to generate the large numbers of high quality stem/progenitor cell subsets needed for Regenerative Medicine settings, as well as for the development of in vitro models for disease modelling and drug testing.

Key words: Stem Cell Engineering, Bioprocessing of Human Induced Pluripotent Stem Cells, Clinical Manufacturing of Stem Cell-based Products, Stem Cell-based disease modelling and drug screening

Major Contributions
  • Clinical manufacturing of human mesenchymal stem/stromal cells for  Regenerative Medicine
  • Bioprocessing of human induced Pluripotent stem cells
  • Designing biomaterials and devices for stem cell engineering

  • Ongoing Activities
  • Organoid engineering for production of microtissues from human pluripotent stem cells
  • Bioreactor platforms for the expansion and differentiation of stem/progenitor cells
  • Clinical manufacturing of stem/progenitor cells and their derivatives
  • Designing biomaterials and devices for stem cell engineering